Literature DB >> 23508576

Hepatocyte divalent metal-ion transporter-1 is dispensable for hepatic iron accumulation and non-transferrin-bound iron uptake in mice.

Chia-Yu Wang1, Mitchell D Knutson.   

Abstract

UNLABELLED: Divalent metal-ion transporter-1 (DMT1) is required for iron uptake by the intestine and developing erythroid cells. DMT1 is also present in the liver, where it has been implicated in the uptake of transferrin-bound iron (TBI) and non-transferrin-bound iron (NTBI), which appears in the plasma during iron overload. To test the hypothesis that DMT1 is required for hepatic iron uptake, we examined mice with the Dmt1 gene selectively inactivated in hepatocytes (Dmt1(liv/liv) ). We found that Dmt1(liv/liv) mice and controls (Dmt1(flox/flox) ) did not differ in terms of hepatic iron concentrations or other parameters of iron status. To determine whether hepatocyte DMT1 is required for hepatic iron accumulation, we crossed Dmt1(liv/liv) mice with Hfe(-) (/) (-) and hypotransferrinemic (Trf(hpx/hpx) ) mice that develop hepatic iron overload. Double-mutant Hfe(-) (/) (-) Dmt1(liv/liv) and Trf(hpx/hpx) ;Dmt1(liv/liv) mice were found to accumulate similar amounts of hepatic iron as did their respective controls. To directly assess the role of DMT1 in NTBI and TBI uptake, we injected (59) Fe-labeled ferric citrate (for NTBI) or (59) Fe-transferrin into plasma of Dmt1(liv/liv) and Dmt1(flox/flox) mice and measured uptake of (59) Fe by the liver. Dmt1(liv/liv) mice displayed no impairment of hepatic NTBI uptake, but TBI uptake was 40% lower. Hepatic levels of transferrin receptors 1 and 2 and ZRT/IRT-like protein 14, which may also participate in iron uptake, were unaffected in Dmt1(liv/liv) mice. Additionally, liver iron levels were unaffected in Dmt1(liv/liv) mice fed an iron-deficient diet.
CONCLUSION: Hepatocyte DMT1 is dispensable for hepatic iron accumulation and NTBI uptake. Although hepatocyte DMT1 is partially required for hepatic TBI uptake, hepatic iron levels were unaffected in Dmt1(liv/liv) mice, suggesting that this pathway is a minor contributor to the iron economy of the liver.
Copyright © 2013 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23508576      PMCID: PMC4572840          DOI: 10.1002/hep.26401

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  40 in total

1.  Both iron deficiency and daily iron supplements increase lipid peroxidation in rats.

Authors:  M D Knutson; P B Walter; B N Ames; F E Viteri
Journal:  J Nutr       Date:  2000-03       Impact factor: 4.798

2.  Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis.

Authors:  R E Fleming; M C Migas; C C Holden; A Waheed; R S Britton; S Tomatsu; B R Bacon; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

3.  ZRT/IRT-like protein 14 (ZIP14) promotes the cellular assimilation of iron from transferrin.

Authors:  Ningning Zhao; Junwei Gao; Caroline A Enns; Mitchell D Knutson
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

Review 4.  Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.

Authors:  Antonello Pietrangelo
Journal:  Gastroenterology       Date:  2010-06-11       Impact factor: 22.682

5.  Internal iron exchange in the rat.

Authors:  B A Cheney; K Lothe; E H Morgan; S K Sood; C A Finch
Journal:  Am J Physiol       Date:  1967-02

6.  ZIP8 is an iron and zinc transporter whose cell-surface expression is up-regulated by cellular iron loading.

Authors:  Chia-Yu Wang; Supak Jenkitkasemwong; Stephanie Duarte; Brian K Sparkman; Ali Shawki; Bryan Mackenzie; Mitchell D Knutson
Journal:  J Biol Chem       Date:  2012-08-16       Impact factor: 5.157

7.  Interdependence of cardiac iron and calcium in a murine model of iron overload.

Authors:  Maya Otto-Duessel; Casey Brewer; John C Wood
Journal:  Transl Res       Date:  2010-12-13       Impact factor: 7.012

8.  A novel N491S mutation in the human SLC11A2 gene impairs protein trafficking and in association with the G212V mutation leads to microcytic anemia and liver iron overload.

Authors:  Edouard Bardou-Jacquet; Marie-Laure Island; Anne-Marie Jouanolle; Lénaïck Détivaud; Nadia Fatih; Martine Ropert; Eolia Brissot; Annick Mosser; Hervé Maisonneuve; Pierre Brissot; Olivier Loréal
Journal:  Blood Cells Mol Dis       Date:  2011-08-26       Impact factor: 3.039

9.  Contrasting uptakes of 59Fe into spleen, liver, kidney and some other soft tissues in normal and hypotransferrinaemic mice. Influence of an antibody against the transferrin receptor.

Authors:  M W Bradbury; K Raja; F Ueda
Journal:  Biochem Pharmacol       Date:  1994-03-15       Impact factor: 5.858

10.  Is the iron donor lipocalin 2 implicated in the pathophysiology of hereditary hemochromatosis?

Authors:  Hua Huang; Shizuo Akira; Manuela M Santos
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

View more
  32 in total

Review 1.  The use of hypotransferrinemic mice in studies of iron biology.

Authors:  Julia T Bu; Thomas B Bartnikas
Journal:  Biometals       Date:  2015-02-08       Impact factor: 2.949

Review 2.  Iron transport proteins: Gateways of cellular and systemic iron homeostasis.

Authors:  Mitchell D Knutson
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

Review 3.  Iron homeostasis: An anthropocentric perspective.

Authors:  Richard Coffey; Tomas Ganz
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

Review 4.  Molecular mediators governing iron-copper interactions.

Authors:  Sukru Gulec; James F Collins
Journal:  Annu Rev Nutr       Date:  2014-06-02       Impact factor: 11.848

5.  Intestinal DMT1 is critical for iron absorption in the mouse but is not required for the absorption of copper or manganese.

Authors:  Ali Shawki; Sarah R Anthony; Yasuhiro Nose; Melinda A Engevik; Eric J Niespodzany; Tomasa Barrientos; Helena Öhrvik; Roger T Worrell; Dennis J Thiele; Bryan Mackenzie
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-20       Impact factor: 4.052

6.  The plasma membrane metal-ion transporter ZIP14 contributes to nontransferrin-bound iron uptake by human β-cells.

Authors:  Richard Coffey; Mitchell D Knutson
Journal:  Am J Physiol Cell Physiol       Date:  2016-11-30       Impact factor: 4.249

Review 7.  Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update.

Authors:  Richard Gordan; Suwakon Wongjaikam; Judith K Gwathmey; Nipon Chattipakorn; Siriporn C Chattipakorn; Lai-Hua Xie
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

8.  Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma.

Authors:  Toshifumi Hoki; Eriko Katsuta; Li Yan; Kazuaki Takabe; Fumito Ito
Journal:  J Surg Res       Date:  2019-02       Impact factor: 2.192

9.  SLC39A14 Is Required for the Development of Hepatocellular Iron Overload in Murine Models of Hereditary Hemochromatosis.

Authors:  Supak Jenkitkasemwong; Chia-Yu Wang; Richard Coffey; Wei Zhang; Alan Chan; Thomas Biel; Jae-Sung Kim; Shintaro Hojyo; Toshiyuki Fukada; Mitchell D Knutson
Journal:  Cell Metab       Date:  2015-05-28       Impact factor: 27.287

10.  Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice.

Authors:  Chia-Yu Wang; Amanda B Core; Susanna Canali; Kimberly B Zumbrennen-Bullough; Sinan Ozer; Lieve Umans; An Zwijsen; Jodie L Babitt
Journal:  Blood       Date:  2017-04-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.